P1.125. Challenging a Histology-Led Paradigm: Comparable Real-World Survival After Definitive Non-Surgical Treatment in Oesophageal Adenocarcinoma and Squamous Cell Carcinoma

Clicks: 1
ID: 325639
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #102 of 453 articles by views in diseases of the esophagus : official journal of the international society for diseases of the esophagus

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 453 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Topic Esophageal Cancer: Oncology/Radiation Therapy Background Histology is often treated as a surrogate for radiosensitivity in oesophageal cancer, sustaining the prevailing assumption that squamous cell carcinoma (SCC) benefits more from definitive chemoradiotherapy than adenocarcinoma (AC). We examined whether overall survival (OS) is better discriminated by histology within a fixed pathway, or by the delivered treatment pathway. Methods Retrospective 10-year single-centre regional cohort of oesophageal cancer treated with radical intent. Patients were grouped by delivered pathway: definitive radiotherapy (dRT), definitive chemoradiotherapy (dCRT), or neoadjuvant chemoradiotherapy (nCRT). Histology-stratified analyses compared AC versus SCC within dCRT and within dRT; a separate SCC-only analysis compared nCRT, dCRT and dRT. OS was measured from decision-to-treat to reduce pathway-dependent lead-time, including chemotherapy cycles before radiotherapy in dCRT patients. Kaplan–Meier methods estimated median OS and landmark OS. Comparisons used log-rank tests (primary) and Gehan–Breslow–Wilcoxon tests (early-event weighting). Cox models generated hazard ratios (HR) with 95% confidence intervals; two-sided p<0.05 was significant. Results Among 553 radical-intent patients (dRT n=278, dCRT n=200, nCRT+S n=75), dCRT showed superior OS versus dRT (median 29.0 vs 19.2 months; 5-year OS 30.0% vs 21.2%; 10-year OS 13.4% vs 3.8%; log-rank p=0.0005). nCRT achieved longer OS than dCRT (median 80.2 vs 29.0 months; 5-year OS 56.2% vs 30.0%; 10-year OS 34.1% vs 13.4%; log-rank p=0.0035). Within dCRT, OS was similar for AC (n=96) and SCC (n=97) (median 31.4 vs 27.1 months; 5-year OS 30.2% vs 29.8%; log-rank p=0.702). Within dRT, AC (n=164) and SCC (n=84) did not differ by log-rank (median 21.4 vs 13.8 months; 5-year OS 21.1% vs 13.8%; p=0.146), despite an early difference (Wilcoxon p=0.0127). In SCC, OS differed markedly by pathway: nCRT (n=67) median 95.4 months with 5-year OS 59.0%; dCRT (n=97) median 27.1 months with 5-year OS 29.8%; dRT (n=84) median 13.8 months with 5-year OS 13.8% (global log-rank p<0.0001). Conclusion In this real-world cohort, survival differed primarily by the treatment pathway delivered, not by histology. Within definitive chemoradiotherapy, AC and SCC had comparable OS, challenging the routine assumption that histology alone predicts benefit. In definitive radiotherapy, early differences without sustained separation were consistent with time-dependent selection rather than durable biology. The practical implication is clear: pathway decisions and service delivery that enable combined-modality radical treatment are likely to influence outcomes more than histology-led expectations.
Reference Key
openalex_W7203944884 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mohammed AlHilali, Anthony Waton, Philip Atherton, Alexander Bradshaw
Journal diseases of the esophagus : official journal of the international society for diseases of the esophagus
Year 2026
DOI
10.1093/dote/doag077.273
URL
https://doi.org/10.1093/dote/doag077.273
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.